30 not yet recruiting. 30 Phase 2, 10 Phase 3, 5 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 30 | Not yet recruiting 30 |
| Phase 3 | 10 | Not yet recruiting 10 |
| Phase 1 | 5 | Not yet recruiting 5 |
Follow Ischemic Stroke: new trials by email Literature Review of Ischemic Stroke trials Research Report on Ischemic Stroke
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| CC-101 (f/k/a NR1) Neural Stem Cell Transplantation for Adults With Chronic Ischemic Stroke CC-101 (f/k/a NR1) Intracerebral Transplantation, Tacrolimus, Sham Surgical Control - Chronic Ischemic Stroke | Phase 2 | Not yet recruiting | Clarion Cells, Inc. | 36 | 2027-01-01 | 2026-07-17 |
| A Phase II Clinical Study of LT3001 for Injection in the Treatment of Acute Ischemic Stroke LT3001 Drug:high dose, LT3001 Drug: low dose, Placebo - Acute Ischemic Stroke | Phase 2 | Not yet recruiting | Shanghai Pharmaceuticals Holding Co., Ltd | 300 | 2026-12-01 | 2026-10-19 |
| A Multicenter, Three-Arm, Open-Label, Endpoint-Blinded Randomized Controlled Trial to Evaluate the Optimal Duration of Early Tirofiban After Intravenous Thrombolysis in Acute Ischemic Stroke Tirofiban Injection, No Interventions - Acute Ischemic Stroke | Phase 2 / Phase 3 | Not yet recruiting | Xinqiao Hospital of Chongqing | 1482 | 2026-11-19 | 2026-09-25 |
| Glucagon-like Peptide-1 Receptor Agonists for Endovascular Stroke Thrombectomy Semaglutide - Ischemic Stroke | Phase 2 | Not yet recruiting | Population Health Research Institute | 100 | 2026-10-31 | 2026-09-24 |
| A Phase 2a Study to Evaluate the Dose-response, Safety, Tolerability, Efficacy, and Population Pharmacokinetics of Intravenous NTS-521 Infusions in the Early Recovery Treatment From Acute Ischemic Stroke NTS-521, Placebo Control - Acute Ischemic Stroke | Phase 2 | Not yet recruiting | NeuroTrauma Sciences, LLC | 140 | 2026-10-31 | 2026-08-03 |
| The Efficacy and Safety of HRS-4029 in Acute Ischemic Stroke Patients HRS-4029, Placebo - Acute Ischemic Stroke | Phase 2 | Not yet recruiting | Beijing Suncadia Pharmaceuticals Co., Ltd | 340 | 2026-10-01 | 2026-10-02 |
| Infarct Growth After Intravenous Tocilizumab in Adults With Acute Ischemic Stroke Undergoing Endovascular Thrombectomy - ILLUMINATE Tociliuzumab, Placebo - Acute Ischemic Stroke | Phase 2 / Phase 3 | Not yet recruiting | Oslo University Hospital | 156 | 2026-09-21 | 2026-10-13 |
| Tirzepatide in Thrombectomy-Treated Acute Ischemic Stroke: A Randomized Trial Tirzepatide, Standard Medical Care (SMC) - Acute Ischemic Stroke (AIS) | Phase 2 / Phase 3 | Not yet recruiting | yifang zhu | 726 | 2026-09-20 | 2026-10-01 |
| Cerebrolysin After Reperfusion in Extended-window EndoVascular Thrombectomy Cerebrolysin, Normal saline placebo - Acute Ischemic Stroke | Phase 2 | Not yet recruiting | Chang Gung Memorial Hospital | 100 | 2026-09-01 | 2026-08-11 |
| A Study of Probiotics in Patients With Acute Ischemic Stroke probiotic supplement OMNi-BiOTiC® SR-9, Matching Placebo - Ischemic Stroke | Phase 2 | Not yet recruiting | Capital Medical University | 220 | 2026-09-01 | 2026-06-17 |
| Investigating Central Contributions to Fatigue Using Non-invasive Brain Stimulation Transcranial alternating current stimulation (tACS), Sham treatment - Stroke, Cerebrovascular Accident (CVA) | Phase 1 / Phase 2 | Not yet recruiting | Vrije Universiteit Brussel | 120 | 2026-09-01 | 2026-05-29 |
| A Phase 2b Trial of Lesion Network Mapping-Guided cTBS for Motor Recovery After Acute Ischemic Stroke LNM-navigated cTBS, Sham cTBS - Ischemic Stroke | Phase 2 | Not yet recruiting | Beijing Tiantan Hospital | 60 | 2026-08-26 | 2026-08-18 |
| Spatiotemporal Evolution of Traditional Chinese Medicine Mechanisms in Acute Ischemic Stroke Treated With Dengzhan Xixin and Dengzhan Shengmai Dengzhan Shengmai - Erigeron breviscapus sequential intervention, corresponding control group sequential intervention - Ischemic Strokes, Traditional Chinese Medicine (TCM) | Phase 2 / Phase 3 | Not yet recruiting | Guangdong Provincial Hospital of Traditional Chinese Medicine | 358 | 2026-06-01 | 2026-05-18 |
| Safety and Efficacy of Human Adipose-Derived Stem Cell Exosomes in Acute Ischemic Stroke Human Adipose-Derived Stem Cell Exosomes, Placebo - Acute Ischemic Stroke | Phase 1 / Phase 2 | Not yet recruiting | Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | 60 | 2026-01-31 | 2026-02-10 |
| Efficacy and Safety of Intra-Arterial Albumin as Adjunct to Mechanical Thrombectomy in Acute Ischemic Stroke 20% human serum albumin - Acute Ischemic Stroke From Large Vessel Occlusion | Phase 2 | Not yet recruiting | Tianjin Huanhu Hospital | 306 | 2026-01-30 | 2026-01-26 |
| Bovis Calculus Stativus Treat Acute Cerebral Ischemic Stroke With Impaired Consciousness Bovis Calculus Stativus (BCS), Placebo - Acute Ischemic Stroke AIS, Impaired Consciousness | Phase 2 / Phase 3 | Not yet recruiting | Xiang Luo | 220 | 2025-12-15 | 2025-12-18 |
| The Preliminary Efficacy and Safety of Intra-Arterial Albumin as Adjunct to Mechanical Thrombectomy in Acute Ischemic Stroke Human serum albumin infusion 20% - Acute Ischemic Stroke From Large Vessel Occlusion | Phase 2 | Not yet recruiting | Tianjin Huanhu Hospital | 60 | 2025-12-10 | 2025-12-19 |
| RK-4 Intracalvariosseous Injection in Treatment of Acute Large Hemispheric Infarction RK-4 injection, conventional treatment - Acute Large Hemispheric Infarction Stroke, Transcranial Bone Marrow Injection | Phase 2 | Not yet recruiting | Fuzhou Neurodawn Rongkang Pharmaceutical Co., Ltd | 194 | 2025-11-01 | 2025-10-02 |
| Clinical Trial of Umbilical Cord Mesenchymal Stem Cells in Subacute Ischemic Stroke Placebo, IxCell hUC-MSC-S (Human Umbilical Cord Mesenchymal Stem Cells) - Ischemic Stroke | Phase 2 | Not yet recruiting | Shanghai IxCell Biotechnology Co., LTD | 86 | 2025-10-01 | 2025-09-29 |
| Efficacy and Safety of Xinglou Chengqi Granule for Acute Ischemic Stroke High-dose Xinglou Chengqi granules, Low-dose Xinglou Chengqi granules and placebo - Acute Ischemic Stroke | Phase 2 | Not yet recruiting | Dongzhimen Hospital, Beijing | 60 | 2025-10-01 | 2025-09-09 |
Showing 20 of 30. Sign in to see all of them.
Stroke (6) · Atrial Fibrillation (1) · Embolic Stroke (1) · Fatigue (1) · Myocardial Infarction (1) · Thrombotic Stroke (1)
Brain Diseases (30) · Cardiovascular Diseases (30) · Central Nervous System Diseases (30) · Cerebrovascular Disorders (30) · Nervous System Diseases (30) · Vascular Diseases (30) · Stroke (24) · Pathological Conditions, Signs and Symptoms (3) · Heart Diseases (2) · Pathologic Processes (2) · Arrhythmias, Cardiac (1) · Infarction (1) · Ischemia (1) · Myocardial Ischemia (1) · Necrosis (1)
Tirofiban (2) · Infusions, Intra-Arterial (1) · Ketamine (1) · Long-Term Synaptic Depression (1) · Midazolam (1) · Population Groups (1) · Saline Solution (1) · Serum Albumin, Human (1) · Tacrolimus (1) · Tirzepatide (1) · Transcranial Direct Current Stimulation (1) · alirocumab (1) · cerebrolysin (1) · edoxaban (1) · evolocumab (1)
Beijing Tiantan Hospital (2) · Tianjin Huanhu Hospital (2) · Affiliated Hospital of Nantong University (1) · Beijing Suncadia Pharmaceuticals Co., Ltd (1) · Capital Medical University (1) · Chang Gung Memorial Hospital (1) · Clarion Cells, Inc. (1) · Dongzhimen Hospital, Beijing (1) · Fuzhou Neurodawn Rongkang Pharmaceutical Co., Ltd (1) · Guangdong Provincial Hospital of Traditional Chinese Medicine (1) · Lower Merion Neurology Research Foundation (1) · Moleac Pte Ltd. (1) · Nanfang Hospital, Southern Medical University (1) · National Taiwan University Hospital (1) · NeuroTrauma Sciences, LLC (1)
China (9) · Canada (1) · Denmark (1) · Norway (1) · Taiwan (1) · United States (1)
Anne Hege Aamodt (1) · Aristeidis Katsanos, MD (1) · Ashkan Shoamanesh, MD (1) · Bijoy A Menon, MD (1) · Christopher Chen, BMBCh, MRCP, FAMS, FRCPE (1) · Gary K Steinberg, MD, PhD (1) · Guodong Xiao, MD.PhD (1) · Mike Sharma, MD (1) · Qiuhong Ji, MD, PhD (1) · Xiang Luo, PhD MD (1) · Xunming Ji, PhD, MD (1) · Zhongming Qiu, MD (1)
PMID 25671797, PMID 26898852, PMID 27296974, PMID 28052979, PMID 29129157, PMID 29364767, PMID 29402504, PMID 30878104, PMID 31662037, PMID 34170647, PMID 34647404, PMID 35259929, PMID 36372278, PMID 37314250, PMID 37952131, PMID 39428602, PMID 39536238, PMID 40702450, PMID 40886075, PMID 41392086, PMID 41500725, PMID 42100960